Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response

Cancer treatment-related adverse events (AEs) are sometimes associated with outcomes for cancer patients, especially with the newest therapies such as target therapy and immunotherapy. A few years ago, the first-line therapy for hormone-receptor-positive metastatic breast cancer (mBC) patients has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasqualoni, Mariangela, Orlandi, Armando, Palazzo, Antonella, Garufi, Giovanna, Cannizzaro, Maria Chiara, Pontolillo, Letizia, Pannunzio, Sergio, Cutigni, Claudia, Sollena, Pietro, Federico, Francesco, Bria, Emilio, Tortora, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034067/
https://www.ncbi.nlm.nih.gov/pubmed/36969030
http://dx.doi.org/10.3389/fonc.2023.1067264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034067/
https://www.ncbi.nlm.nih.gov/pubmed/36969030
http://dx.doi.org/10.3389/fonc.2023.1067264

Ejemplares similares